Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2000
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007026A1 Integrin antagonists
06/14/2000EP0871606B1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
06/14/2000CN1256147A Medicinal liquor for treating rheumatism and its preparation
06/14/2000CN1053441C Compound with 1-(aryl china olefine)-4-(aryl methyl) piperazine structure, its preparation process and medicine containing the compound thereof
06/13/2000US6075020 Method of regulating immune function
06/13/2000US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome
06/13/2000US6074642 Reduce cell lysing ability of biological complement present in blood
06/13/2000CA1341026C Il-1 inhibitors process for producing il-1 inhibitors and for using such inhibitors in therapy
06/13/2000CA1341023C Peptide derivatives
06/08/2000WO2000032816A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
06/08/2000WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS
06/08/2000WO2000032766A1 Human vanilloid receptors and their uses
06/08/2000WO2000032764A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000WO2000032638A1 Polysaccharide chiral esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or chiral chromatography
06/08/2000WO2000032634A1 Humanized antibodies to gamma-interferon
06/08/2000WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032593A1 Method of producing paroxetine hydrochloride
06/08/2000WO2000032587A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
06/08/2000WO2000032584A2 Nonsteroidal antiinflammatories
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000032575A1 β-ALANINE DERIVATIVES AS α4 INTEGRIN INHIBITORS
06/08/2000WO2000032570A1 Hydrazine derivatives
06/08/2000WO2000032567A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
06/08/2000WO2000032235A1 Transport system conjugate
06/08/2000WO2000032234A1 Topical compositions comprising ascomycins
06/08/2000WO2000032219A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000WO2000032189A1 Celecoxib compositions
06/08/2000WO2000032188A2 Use of amtolmetin guacyl as an antiinflammatory drug
06/08/2000WO2000032168A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases
06/08/2000WO2000032165A1 Milling process for the production of finely milled medicinal substances
06/08/2000WO2000016760A3 New use of prostaglandin e2 antagonists
06/08/2000WO2000011191A3 Tpl-2/cot kinase and methods of use
06/08/2000WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
06/08/2000WO1999058095A3 Pharmaceutical and/or cosmetic compositions containing sea water
06/08/2000CA2634658A1 Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations
06/08/2000CA2353702A1 Polysaccharide chiral esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or chiral chromatography
06/08/2000CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000CA2353402A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
06/08/2000CA2353090A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000CA2352555A1 Transport system conjugate
06/08/2000CA2352539A1 Recombinant soluble fc receptors
06/08/2000CA2352487A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases
06/08/2000CA2352388A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/08/2000CA2351321A1 Hydrazine derivatives
06/08/2000CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000CA2347701A1 .beta.-alanine derivatives as .alpha.4 integrin inhibitors
06/08/2000CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2000EP1006183A1 Recombinant soluble Fc receptors
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005463A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same
06/07/2000EP1005460A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
06/07/2000EP1005459A1 Substituted isoquinolines as anticonvulsivants
06/07/2000EP1005445A1 N-alkanoylphenylalanine derivatives
06/07/2000EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases
06/07/2000EP1005351A1 An aqueous metal bicarbonate solution and method of use
06/07/2000EP0840606B1 Di- and trivalent small molecule selectin inhibitors
06/07/2000CN1255857A Histone containing compsn. to treat rheumatoid arthritis
06/07/2000CN1255852A Novel method and compsns. for drug feeding of taxad alkyl compounds
06/07/2000CN1255848A Process for making flurbiprofen lozenges
06/07/2000CN1255364A Antalgic spray and its preparing process
06/07/2000CN1053193C Esculetin derivatives, process for manufacture and use thereof, and pharmaceutical compsn.
06/07/2000CN1053187C Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
06/06/2000US6072037 Antibodies to the IL-17 receptor
06/06/2000US6072033 Receptor that binds IL-17
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071927 Tachykinnin antagonists for the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
06/06/2000US6071919 Stimulate the immunological system and to induce the production of hypercellular bone marrow and extramedullary hematopoiesis; antitumor and -carcinogenic agents; autoimmune diseases; viricides; hepatitis
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071899 Azetidinone derivatives for the treatment of atherosclerosis
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071890 Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
06/06/2000US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery
06/06/2000US6071519 Treating autoimmune diseases, hodgkin's disease and other lymph cancers
06/02/2000WO2000031289A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031248A1 Humanized monoclonal antibodies
06/02/2000WO2000031244A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
06/02/2000WO2000031120A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
06/02/2000WO2000031113A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN
06/02/2000WO2000031109A1 USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION
06/02/2000WO2000031100A2 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031095A2 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031094A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031093A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031084A1 Prostaglandin conjugates for treating or preventing bone disease
06/02/2000WO2000031083A1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
06/02/2000WO2000031067A1 Propanoic acid derivatives as integrin inhibitors
06/02/2000WO2000031065A1 Compounds having cytokine inhibitory activity
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000WO2000031054A1 Il-5 inhibiting 6-azauracil derivatives
1 ... 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 ... 1272